TrialLeukemia2025

Outcomes of patients treated with venetoclax plus azacitidine versus azacitidine alone stratified by advanced age and acute myeloid leukemia composite model.

Adriano Venditti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.